JPRN-UMIN000038238已完成未知
Effect of topiroxostat on diabetic nephropathy in patients with type 2 diabetes mellitus - Effect of topiroxostat on diabetic nephropathy in patients with type 2 diabetes mellitus
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University0 个研究点目标入组 20 人开始时间: 2019年10月8日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1.patients with pregnancy 2.patients with severe infection or trauma, or under surgery 3.patients who have alcohol-induced liver injury 4.patients whose general conditions are seriously ill 5.patients who are allergic to antihyperuricemics 6.patients with serious commodities or who are judged not to be suitable for this study
研究者
相似试验
尚未招募
不适用
The effect of topiroxostat on renal function in type2 diabetes with hyperuricemiatype 2 diabetes with serum uric acid levels more than 7 mg/dl and eGFR more than 60 mL/min/1.73m2JPRN-UMIN000022644Osaka City University Graduate School of Medicine20
已完成
不适用
The effect of topirxostat on hemodialysis patient with hyperuricemiahyperuricemiaJPRN-UMIN000026620TM50
已完成
不适用
Study on the influence of Topiroxostat on renal functiohyperuricemiaJPRN-UMIN000034118Sato Clinic59
已完成
不适用
Influence of febuxostat and Topiroxostat on renal functiohyperuricemiaJPRN-UMIN000014771Sekino Hospital50
已完成
不适用
Effects of linagliptin on diabetic nephropathy in CKD patientsJPRN-UMIN000010952Kurume University School of Medicine60
